Logos Global Management LP Q1 2025 Filing
Filed May 15, 2025
Portfolio Value
$562.5B
Holdings
39
Report Date
Q1 2025
Filing Type
13F-HR
All Holdings (39 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | IDYAIDEAYA BIOSCIENCES INC | 3,500,000 | $57.3B | 10.19% | |
| 2 | RVMDREVOLUTION MEDICINES INC | 1,600,000 | $56.6B | 10.06% | |
| 3 | AKROAKERO THERAPEUTICS INC | 1,200,000 | $48.6B | 8.64% | |
| 4 | JANXJANUX THERAPEUTICS INC | 1,650,000 | $44.5B | 7.92% | |
| 5 | NUVLNUVALENT INC | 500,000 | $35.5B | 6.30% | |
| 6 | TEVATEVA PHARMACEUTICAL INDS LTD | 1,700,000 | $26.1B | 4.64% | |
| 7 | XENEXENON PHARMACEUTICALS INC | 650,000 | $21.8B | 3.88% | |
| 8 | KROSKEROS THERAPEUTICS INC | 2,000,000 | $20.4B | 3.62% | |
| 9 | IRONDISC MEDICINE INC | 394,342 | $19.6B | 3.48% | |
| 10 | BNTXBIONTECH SE | 200,000 | $18.2B | 3.24% | |
| 11 | ETNBGBP89BIO INC | 2,500,000 | $18.2B | 3.23% | |
| 12 | SLNOSOLENO THERAPEUTICS INC | 250,000 | $17.9B | 3.18% | |
| 13 | ERASERASCA INC | 13,000,000 | $17.8B | 3.17% | |
| 14 | OCULOCULAR THERAPEUTIX INC | 2,300,000 | $16.9B | 3.00% | |
| 15 | DSGNDESIGN THERAPEUTICS INC | 4,217,627 | $16.3B | 2.89% | |
| 16 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 350,000 | $13.7B | 2.43% | |
| 17 | GONGERON CORP | 8,000,000 | $12.7B | 2.26% | |
| 18 | OLMAOLEMA PHARMACEUTICALS INC | 3,208,875 | $12.1B | 2.14% | |
| 19 | CRNXCRINETICS PHARMACEUTICALS IN | 350,000 | $11.7B | 2.09% | |
| 20 | RNAAVIDITY BIOSCIENCES INC | 350,000 | $10.3B | 1.84% | |
| 21 | MAZEMAZE THERAPEUTICS INC | 936,914 | $10.3B | 1.83% | |
| 22 | ANNXANNEXON INC | 4,000,000 | $7.7B | 1.37% | |
| 23 | GPCRSTRUCTURE THERAPEUTICS INC | 425,000 | $7.4B | 1.31% | |
| 24 | CMPSCOMPASS PATHWAYS PLC | 2,000,000 | $5.7B | 1.02% | |
| 25 | DYNDYNE THERAPEUTICS INC | 500,000 | $5.2B | 0.93% | |
| 26 | ELVNENLIVEN THERAPEUTICS INC | 240,000 | $4.7B | 0.84% | |
| 27 | IMVTIMMUNOVANT INC | 275,000 | $4.7B | 0.84% | |
| 28 | AVTEAEROVATE THERAPEUTICS INC | 1,400,000 | $3.5B | 0.62% | |
| 29 | ACRSACLARIS THERAPEUTICS INC | 2,222,222 | $3.4B | 0.60% | |
| 30 | UNCYUNICYCIVE THERAPEUTICS INC | 5,078,927 | $2.9B | 0.52% | |
| 31 | TRVITREVI THERAPEUTICS INC | 424,715 | $2.7B | 0.47% | |
| 32 | CATBUSDASTRIA THERAPEUTICS INC | 500,000 | $2.7B | 0.47% | |
| 33 | RAPPRAPPORT THERAPEUTICS INC | 208,910 | $2.1B | 0.37% | |
| 34 | GLYCEURGLYCOMIMETICS INC | 5,400,000 | $1.1B | 0.20% | |
| 35 | SEPNSEPTERNA INC | 134,202 | $777.0M | 0.14% | |
| 36 | ALLKGUSDALLAKOS INC | 2,900,000 | $660.0M | 0.12% | |
| 37 | ARTVARTIVA BIOTHERAPEUTICS INC | 145,089 | $435.3M | 0.08% | |
| 38 | SLDBSOLID BIOSCIENCES INC | 100,000 | $370.0M | 0.07% | |
| 39 | NUVB/WSNUVATION BIO INC | 66,666 | $15.9M | 0.00% |